United Therapeutics Corporation (UTHR)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 1,377,000 | 1,184,900 | 979,700 | 555,900 | 593,600 |
| Total assets | US$ in thousands | 7,364,000 | 7,167,000 | 6,044,500 | 5,169,100 | 4,615,000 |
| Operating ROA | 18.70% | 16.53% | 16.21% | 10.75% | 12.86% |
December 31, 2024 calculation
Operating ROA = Operating income ÷ Total assets
= $1,377,000K ÷ $7,364,000K
= 18.70%
United Therapeutics Corporation's operating return on assets (Operating ROA) has shown fluctuations over the last five years.
- In 2020, the Operating ROA was 12.86%, indicating that for every dollar of assets, the company generated a profit of 12.86 cents.
- In 2021, the Operating ROA decreased to 10.75%, reflecting a decline in the company's efficiency in utilizing its assets to generate profits.
- However, in 2022, there was a significant improvement in the Operating ROA to 16.21%, demonstrating a better utilization of assets to generate profits.
- This positive trend continued in 2023, with the Operating ROA further increasing to 16.53%.
- By the end of 2024, the Operating ROA reached 18.70%, indicating that the company was able to significantly improve its profitability relative to its asset base.
Overall, the increasing trend in the Operating ROA from 2021 to 2024 suggests that United Therapeutics Corporation has been able to enhance its operational efficiency and profitability in utilizing its assets effectively. This improvement in Operating ROA signifies the company's ability to generate higher returns from its assets, which is a positive indicator of financial performance.
Peer comparison
Dec 31, 2024